Sen. Charles Grassley (R-Iowa) requested information from two hospitals and a health system in North Carolina about how they are using the 340B federal drug discount program.
The request is in response to media reports that the providers–402-bed Carolinas Medical Center in Concord, 786-bed University of North Carolina Health Care in Chapel Hill and the three-hospital Duke University Health System in Durham–have charged more for certain cancer drugs, compared with prices charged by community oncologists.
Grassley said in a Sept. 28 letter to Duke University Health System President and CEO Victor Dzau that he is concerned the hospitals are purchasing drugs at 340B discounts without passing on the savings to patients.
"If 'non-profit' hospitals are essentially profiting from the 340B program without passing those savings on" to patients, "then the 340B program is not functioning as intended," Grassley wrote.